While high success rates in treating patients tested positive for COVID-19 are achieved in France, using a chloroquine-based treatment, Canadian governmental bodies and professional associations
“I am a doctor first,” emphasizes Hugo Sigman (75), who is also the owner of the Insud pharmaceutical group and a film producer. You are, you
(ANSA) – Rome, March 27 – Anti-malarial drugs chloroquine and hydroxychloroquine have been authorized in Italy to treat patients infected with Sars-Cov2, according to a
«En dehors d’un protocole de recherche, l’usage devrait être limité à des patients dont la situation clinique est sévère, évaluée au cas par cas, soutenu
This is an excellent interview if you seek to understand the sickness. Dr Zelenko does an excellent pedagogic job here. And he explains how he
This summarizes pretty well the fate of the hydroxychloroquine azitromycin treatment, while there are numerous research programs now being started, with double blinded protocols. Researchers
There is an interesting opinion piece dated March 26 in the Globe and Mail, suggesting to give the hydroxychloroquine treatment a chance. At the same
See Facebook video
Eric Chabrière, one of the most renowned professors working with Professor Didier Raoult, comments the situation of the epidemic as of March 28 as well
Eric Chabrière, l’un des professeurs les plus réputés autour de Didier Raoult, commente en exclusivité pour notre groupe, la situation de l’épidémie en ce 28 mars
Former health minister, Philippe Douste-Blazy, advocates early treatment of patients.
“The controversial coronavirus drug that a Hasidic doctor has been using to treat hundreds of people with moderate symptoms in upstate N.Y. is also being
November 9, 2020 by Peter A. McCullough, MD, MPH, FACC, FACP, FAHA, FCCP, FNKF, FNLA, FCRSA1 2 3 4 5 1Baylor University Medical… (62)
Greetings and welcome. COVEXIT.com offers you independent global news and policy analysis regarding COVID-19, with emphasis on early treatments.
We are on Spotify and Apple Podcasts! Check our page listing all our podcasts.
We are on Twitter and also on GAB and Mewe.
Bonjour. Nous aurons prochainement du contenu nouveau via Substack. Vous êtes invité à vous y abonner!
